Neurocrine Bioscience buy Needham & Company LLC
Start price
06.04.26
/
50%
€113.60
Target price
06.04.27
€160.60
Performance (%)
16.11%
Price
19.08.26
€133.20
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 16.11%. This prediction currently runs until 06.04.27. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.951% | -1.951% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $185.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.60
31.07.26
31.07.26
€177.24
31.07.27
31.07.27
-10.36%
19.08.26
19.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
7.07%
19.08.26
19.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
10.28%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
27.81%
16.04.26
16.04.26